Joint Committee of Public Accounts and Audit
Review of Auditor-General's Reports 1999-00, Second Quarter
List of recommendations
Chapter 2 : Audit Report No. 13 Management of Major Equipment Acquisition
Projects, Department of Defence
Recommendation 1
The Committee recommends that the Defence Audit and Program Evaluation
Committee ensure that Australian National Audit Office and JCPAA recommendations
are monitored and reviewed in a timely manner. (Paragraph 2.27)
Recommendation 2
The Committee recommends that the Australian National Audit Office consider
carrying out a follow-up audit, in the next eighteen months to two years,
on the management of major Defence acquisition projects.(Paragraph 2.69)
Chapter 3: Audit Report No. 14 Commonwealth Debt Management
Recommendation 3
The Committee recommends that the Australian Office of Financial Management
take action to obtain and maintain the high level of in-house expertise
required to enhance its own management and to retain control and exercise
judgment over external adviser inputs.(Paragraph 3.22)
Recommendation 4
The Committee recommends that the Australian Office of Financial Management
put processes in place to monitor risks and identify weaknesses which
may impact on the appropriateness or timing of the portfolio benchmark
review process.(Paragraph 3.37)
Recommendation 5
The Committee recommends that the Australian Office of Financial Management
move as quickly as possible to implement all of the Australian National
Audit Office recommendations. (Paragraph 3.82)
Chapter 4: Audit Report No. 24 Commonwealth Management and
Regulation of Plasma Fractionation
Recommendation 6
The Committee recommends that the Department of Health and Aged Cares
Audit Committee conduct regular internal audits of the Therapeutic Goods
Administrations performance, and provide to the Committee by December
2001 an updated status report of the effectiveness of the Therapeutic
Goods Administrations implementation of its auditing program of Commonwealth
Serum Laboratories compliance with the Code of Good Manufacturing Practice,
including the extent to which the Therapeutic Goods Administration is
complying with its own procedures and practices for undertaking these
audits.(Paragraph 4.30)
Recommendation 7
The Committee recommends that Commonwealth Serum Laboratories be required
on a regular basis to provide positive declarations to the Therapeutic
Goods Administration regarding the volume, source and final destination
of all foreign plasma imported into Australia by the company and processed
at its Broadmeadows fractionation plant. (Paragraph 4.31)
Recommendation 8
The Committee recommends that agencies implement administrative arrangements
to ensure that the Therapeutic Goods Administration is notified of
all Quarantine Entries made by the Australian Quarantine Inspection
Service of human blood and blood products imported into Australia.(Paragraph
4.32)
Recommendation 9
The Committee recommends that the Chief Executive Officer of the Department
of Health and Aged Care assess the skill base and training needs of its
contract managers, and ensure that appropriate legal and technical advice
is readily available to them. (Paragraph 4.56)
Recommendation 10
The Committee recommends that the Australian National Audit Office undertake
a timely performance audit of the Department of Health and Aged Cares
handling of the Plasma Fractionation Agreement extension review. (Paragraph
4.57)